Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients [Phase 1]
Phase 1 study evaluating PN20 to prevent chemotherapy-induced thrombocytopenia in patients with lymphoma or solid tumors; the trial has comp…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: HeartPhone Cancer Survivors Trial 2019 [Phase 1, Phase 2]
The HeartPhone Cancer Survivors Trial (Phase 1/2) sponsored by Penn State University was terminated; results have been posted for breast can…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Virtual Rehabilitation for Cancer Survivors [NA]
A clinical trial update indicates a virtual rehabilitation program for cancer survivors is currently recruiting across multiple cancer types…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Pembrolizumab for Patients With PD-L1 Diffuse Large B Cell Lymphoma (DLBCL) [Phase 2]
A Phase 2 trial of pembrolizumab in PD-L1–expressing Diffuse Large B-Cell Lymphoma was terminated, and results were posted on February 20, 2…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults [EARLY_Phase 1]
A Phase 1 trial evaluating pembrolizumab in combination with decitabine and hypofractionated radiation in pediatric and young adult patients…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma [Phase 1]
A Phase 1 trial of CUDC-907 (fimepinostat) in children and young adults with relapsed or refractory solid tumors, CNS tumors, or lymphoma ha…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Cardiovascular Effects of CART Cell Therapy
A completed clinical trial update investigates the cardiovascular effects of CAR-T cell therapy in leukemia and lymphoma patients.
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas [Phase 1]
Phase 1 study evaluating CD45RA+ depleted haploidentical stem cell transplantation in children with relapsed or refractory solid tumors and …
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors [Phase 1, Phase 2]
Clinical trial update reporting Phase 1/2 results for Elimusertib in relapsed or refractory solid tumors, including alveolar rhabdomyosarcom…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Removing Transfusion Dependence as a Barrier to Hospice Enrollment [NA]
A completed clinical trial update indicates that transfusion dependence was removed as a barrier to hospice enrollment for patients with hem…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Sarcoidosis Immunotsuppressive Therapy and Lymphoma Development
A completed trial update on immunosuppressive therapy for sarcoidosis noting the development of lymphoma as an adverse outcome observed duri…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas [Phase 1, Phase 2]
Results from a Phase 1/2 study of ALRN-6924 in patients with advanced solid tumors and lymphomas have been posted after completion of the tr…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: To Evaluate a Phase I/II Clinical Study of XNW5004 Tablets in Patients With Relapsed/Refractory Advanced Tumors [Phase 1, Phase 2]
This update reports the completion of a Phase I/II clinical trial evaluating XNW5004 tablets in patients with relapsed/refractory advanced s…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Image-guided Lymphadanectomy in AMIGO [NA]
The clinical trial NCT03283423, titled 'Image-guided Lymphadanectomy in AMIGO' and sponsored by Brigham and Women's Hospital, has been termi…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Strength Training Exercises to Minimise Late Effects of Childhood Leukaemia or Lymphoma Among Adolescents [NA]
This completed clinical trial investigates strength training to minimize late effects in adolescents who survived childhood leukemia or lymp…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Study of the Angiogenesis by PET/CT in Patients With Lymphoma [Phase 2]
This update notes the completion of a Phase 2 clinical trial evaluating angiogenesis assessment by PET/CT imaging in patients with lymphoma.
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: A Study of LY3039478 in Participants With Advanced Cancer [Phase 1]
Phase 1 trial of LY3039478 in participants with advanced cancer completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation [Phase 1, Phase 2]
Phase 1/2 trial evaluating GVHD prophylaxis with post-transplant cyclophosphamide plus sirolimus and VIC-1911 in myeloablative peripheral bl…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia [Phase 1]
A Phase 1 feasibility and safety study of dual CD19/CD22 CAR-T cell therapy for CD19+CD22+ leukemia, with the trial currently active but not…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T) [NA]
Clinical trial update on adaptive bridging radiotherapy for relapsed/refractory B-cell lymphomas prior to CAR-T therapy; the study status is…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Genetic Changes (MATCH-Subprotocol N) [Phase 2]
Phase 2 MATCH subprotocol update evaluating GSK2636771 for cancers with PTEN genetic changes; results were posted in 2025.
-
CLINICAL_TRIALS trial_result · 2025-10-27Clinical Trial Update: Resiliency in Older Adults Undergoing Bone Marrow Transplant
A completed clinical trial update from Johns Hopkins on resiliency in older adults undergoing bone marrow transplant for hematologic cancers…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Loss of Expression (MATCH-Subprotocol P) [Phase 2]
Phase 2 trial update evaluating GSK2636771 in cancers with PTEN loss under the MATCH program; the study is active but not recruiting and res…
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy [Phase 2]
Phase 2 trial of ofatumumab for minimal residual disease and maintenance therapy in leukemia and lymphoma was terminated; results have been …
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: Retun-to-school Adaptation Program for Children With Cancer [NA]
Clinical trial update indicating the completion of a return-to-school adaptation program study for children with cancer, sponsored by Gazi U…